COVID-19 infection and pulmonary sarcoidosis: a systematic review and meta-analysis of morbidity, severity and mortality
Peer-Reviewed Publication
Updates every hour. Last Updated: 13-May-2025 19:09 ET (13-May-2025 23:09 GMT/UTC)
Key findings
• Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 (COVID-19).
What is known and what is new?
• Subjects with sarcoidosis are more vulnerable to SARS-CoV-2 infection.
• Severity of COVID-19 was also more serious in subjects stricken with sarcoidosis.
What is the implication, and what should change now?
• Vaccination against SARS-CoV-2 for sarcoidosis may be a compulsory measure.